Provided by Tiger Fintech (Singapore) Pte. Ltd.

EyePoint

6.65
+0.07001.06%
Volume:164.98K
Turnover:1.09M
Market Cap:453.87M
PE:-3.26
High:6.79
Open:6.33
Low:6.25
Close:6.58
Loading ...

Stock Track | EyePoint Shares Plummet on $100M Stock Offering Despite Positive Trial Data

Stock Track
·
30 Oct 2024

Stock Track | EyePoint Surges Over 5% on Positive Duravyu Clinical Updates

Stock Track
·
29 Oct 2024

EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
29 Oct 2024

EyePoint Pharmaceuticals (EYPT) Soars 27.6%: Is Further Upside Left in the Stock?

Zacks
·
29 Oct 2024

Stock Track | EyePoint Pharmaceuticals Plunges After $100M Stock Offering Overshadows Positive Trial Data

Stock Track
·
29 Oct 2024

Stock Track | EyePoint Shares Plunge After $100M Stock Offering Amid Positive Trial Data

Stock Track
·
29 Oct 2024

BUZZ-EyePoint slides after unveiling $100 mln stock offering

Reuters
·
29 Oct 2024

EyePoint announces $100M offering of common stock

TIPRANKS
·
29 Oct 2024

EyePoint Pharmaceuticals Inc - Commences $100 Million Public Offering

THOMSON REUTERS
·
29 Oct 2024

EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
29 Oct 2024

EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss

Benzinga
·
29 Oct 2024

EyePoint Pharmaceuticals Shares Rise 35% on Positive Clinical Trial Data for Duravyu

Dow Jones
·
29 Oct 2024

EyePoint Pharmaceuticals’ Positive Clinical Data Boosts Buy Rating Amid Promising Eye Disease Therapies

TIPRANKS
·
28 Oct 2024

EyePoint Pharmaceuticals Inc : Jefferies Raises Target Price to $27 From $15

THOMSON REUTERS
·
28 Oct 2024

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday

Benzinga
·
28 Oct 2024

BUZZ-EyePoint rises after positive data from eye disease drug trial

Reuters
·
28 Oct 2024